Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension

May 2011
Diabetes Care;May2011 Supplement 2, Vol. 34, pS297
Academic Journal
The article offers an interpretation of the UK Prospective Diabetes Study (UKPDS) which examined the sustained effects of improved glycemic control after years of extended follow-up in type 2 diabetic patients. The sustained effects, also known as legacy effect, aims to address the long-term emergent and/or sustained benefits of glycemic control. Details of other studies conducted to assess the early benefits of glycemic control are presented. A main determinant of the prognostic benefit of anti-hypertensive treatment is blood pressure (BP) reduction.


Related Articles

  • Sustained Glycaemic Control over 6 Years in a Large Outpatient Cohort Using a Repeatedly Implemented Aggressive Treatment Protocol. Mulcahy, Michael P.; Emmanuel, Julien; Gable, David // Diabetes;Jun2007 Supplement 1, Vol. 56, pA142 

    We undertook a long term prospective cohort study to ascertain whether evidence based glycaemic, lipid and blood pressure (BP) targets could be achieved and sustained in a District General Hospital (DGH) setting. We instigated an aggressive and continuously updated treatment protocol focusing on...

  • Better diabetes control needed among Haitian patients. Foster, Melissa // Endocrine Today;Jan2011, Vol. 9 Issue 1, p25 

    This article discusses a study on glycemic and blood pressure control among Haitians with diabetes.

  • Growing diabetes problem signals adherence challenges. BENDIX, JEFFREY // Medical Economics;6/10/2013, Vol. 90 Issue 11, p20 

    The article focuses on diabetes and its management. As stated in a report by the American Diabetes Association (ADA), the disease has an increase rate from 7-8 percent. Its management includes lifestyle changes along with drugs with three of its main symptoms being blood pressure, low-density...

  • Antihypertensive Treatment and Resistant Hypertension in Patients With Type 1 Diabetes by Stages of Diabetic Nephropathy. Lithovius, Raija; Harjutsalo, Valma; Forsblom, Carol; Saraheimo, Markku; Groop, Per-Henrik // Diabetes Care;Mar2013, Vol. 37 Issue 3, p709 

    OBJECTIVE To assess blood pressure (BP) control, antihypertensive treatment, and prevalence of resistant hypertension (RH) in patients with type 1 diabetes stratified by stage of diabetic nephropathy. RESEARCH DESIGN AND METHODS This cross-sectional study included a nationally representative...

  • The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Rossing, P. // Diabetologia;Aug2005, Vol. 48 Issue 8, p1439 

    Diabetic microvascular complications in the kidney and the eye are a major burden for diabetic patients due to increased morbidity and mortality. Furthermore, diabetic nephropathy is the leading cause of end-stage renal disease and diabetic retinopathy is the leading cause of blindness in...

  • Diabetes and GMS2: sensible and achievable targets? Hughes, Eugene; Barrett-Lee, P. // Update;5/6/2004, Vol. 68 Issue 8, p389 

    The targets for diabetes and the new GMS contract are deemed by some to be 'unrealistic' or 'unachievable.' There has been argument about the inclusion of some indicators and the exclusion of others. With regard to inclusion, the author says to the detractors that the new contract is an...

  • A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome. Racine, N.; Hamet, P.; Sampalis, J. S.; Longo, N.; Bastien, N. // Journal of Human Hypertension;Nov2010, Vol. 24 Issue 11, p739 

    The impact of an ARB, with or without hydrochlorothiazide (HCTZ), on glycaemic factors and the risk for developing diabetes in hypertensive patients with the metabolic syndrome have not been fully assessed. This was a 52-week multicentre, prospective, phase-IV, open-label, cohort study of...

  • Weight Lost and Regained Still Helps in Diabetes.  // Clinician Reviews;Oct2008, Vol. 18 Issue 10, p16 

    The article discusses research being done on weight change and diabetes. It references a study by A. C. Feldstein et al, published in a 2008 issue of "Diabetes Care." Researchers revealed that weight loss has beneficial effects on glycemic and blood pressure control among diabetic persons. Data...

  • Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Beaton, Sarah J.; Nag, Soma S.; Gunter, Margaret J.; Gleeson, Jeremy M.; Sajjan, Shiva S.; Alexander, Charles M. // Diabetes Care;Mar2004, Vol. 27 Issue 3, p694 

    Objective: We conducted a retrospective study to evaluate the adequacy of glycemic, lipid, and blood pressure (BP) management for diabetic patients in a managed care organization (MCO).Research Design and Methods: Patients aged > or =18 years with diabetes (n=7,114)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics